Change Healthcare Joint Development Agreement (Details) - Joint Development Agreement and Data Licensing Agreement - USD ($)
$ / shares in Units, $ in Thousands |
1 Months Ended |
|
Feb. 29, 2020 |
May 31, 2021 |
| Maximum |
|
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
| Cumulative royalty payments |
$ 2,500
|
|
| Change Healthcare Holdings |
|
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
| License agreement term (in years) |
5 years
|
|
| License agreement renewal term (in years) |
5 years
|
|
| Remainder of 2022 |
|
$ 161
|
| 2023 |
|
230
|
| 2024 |
|
245
|
| 2025 |
|
260
|
| Total |
|
$ 896
|
| Change Healthcare Holdings | Other Assets |
|
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
| Capitalized equity cost |
$ 3,005
|
|
| Change Healthcare Holdings | Restricted shares |
|
|
| Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] |
|
|
| Granted |
251,211
|
|
| Estimated fair value of common stock |
$ 15.40
|
|
| Aggregate value of shares |
$ 3,869
|
|
| Vested shares |
150,727
|
|
| Non-vested shares |
100,484
|
|